PEGylation strategies for enhanced nanoparticle delivery to tumor-associated immune cells.

Cahn D, Pal S, Stern A, Patel NL, Gower T, Kapnick SM, Jewell CM, Duncan GA, Wolf MT

Open source

DOI
10.1002/btm2.70098
Published
2026 May
Container
Bioengineering & translational medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/btm2.70098,
  title = {PEGylation strategies for enhanced nanoparticle delivery to tumor-associated immune cells.},
  author = {Cahn D and Pal S and Stern A and Patel NL and Gower T and Kapnick SM and Jewell CM and Duncan GA and Wolf MT},
  year = {2026},
  journal = {Bioengineering \& translational medicine},
  doi = {10.1002/btm2.70098},
  url = {https://doi.org/10.1002/btm2.70098}
}

RIS

TY  - JOUR
TI  - PEGylation strategies for enhanced nanoparticle delivery to tumor-associated immune cells.
AU  - Cahn D
AU  - Pal S
AU  - Stern A
AU  - Patel NL
AU  - Gower T
AU  - Kapnick SM
AU  - Jewell CM
AU  - Duncan GA
AU  - Wolf MT
PY  - 2026
JO  - Bioengineering & translational medicine
DO  - 10.1002/btm2.70098
UR  - https://doi.org/10.1002/btm2.70098
ER  - 

APA

D, C., S, P., A, S., NL, P., T, G., SM, K., CM, J., GA, D., & MT, W. (2026). PEGylation strategies for enhanced nanoparticle delivery to tumor-associated immune cells.. Bioengineering & translational medicine. https://doi.org/10.1002/btm2.70098

Source records